PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 217 filers reported holding PTC THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $883,716 | -44.9% | 39,434 | +0.3% | 0.00% | -33.3% |
Q2 2023 | $1,602,520 | -13.3% | 39,312 | +3.0% | 0.00% | -25.0% |
Q1 2023 | $1,849,100 | +49.8% | 38,173 | +18.0% | 0.00% | +33.3% |
Q4 2022 | $1,234,570 | -21.7% | 32,344 | +3.1% | 0.00% | -25.0% |
Q3 2022 | $1,576,000 | +75.5% | 31,379 | +40.1% | 0.00% | +100.0% |
Q2 2022 | $898,000 | -85.4% | 22,404 | -82.7% | 0.00% | -90.5% |
Q1 2021 | $6,135,000 | +43.1% | 129,565 | +84.5% | 0.02% | +31.2% |
Q4 2020 | $4,286,000 | +124.3% | 70,220 | +71.8% | 0.02% | +60.0% |
Q3 2020 | $1,911,000 | +34.7% | 40,865 | +46.1% | 0.01% | +11.1% |
Q2 2020 | $1,419,000 | +41.8% | 27,977 | +24.7% | 0.01% | +12.5% |
Q1 2020 | $1,001,000 | +4.3% | 22,437 | +12.2% | 0.01% | +33.3% |
Q4 2019 | $960,000 | +52.4% | 19,992 | +7.2% | 0.01% | +50.0% |
Q3 2019 | $630,000 | +160.3% | 18,642 | +246.1% | 0.00% | +100.0% |
Q2 2019 | $242,000 | -81.0% | 5,387 | -85.5% | 0.00% | -81.8% |
Q4 2018 | $1,271,000 | -15.5% | 37,036 | +15.7% | 0.01% | 0.0% |
Q3 2018 | $1,504,000 | -1.8% | 32,000 | -44.2% | 0.01% | -82.5% |
Q3 2015 | $1,531,000 | -15.6% | 57,358 | +52.2% | 0.06% | +8.6% |
Q2 2015 | $1,814,000 | – | 37,688 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RTW INVESTMENTS, LP | 7,235,196 | $162,140,742 | 3.42% |
Camber Capital Management LP | 3,400,000 | $76,194 | 2.51% |
ARMISTICE CAPITAL, LLC | 6,150,000 | $137,821,500 | 2.11% |
GREAT POINT PARTNERS LLC | 500,000 | $11,205,000 | 2.04% |
COWEN AND COMPANY, LLC | 799,511 | $17,917,041 | 1.25% |
GEORGE KAISER FAMILY FOUNDATION | 45,816 | $6,491,211 | 1.22% |
SPHERA FUNDS MANAGEMENT LTD. | 218,459 | $4,895,666 | 0.89% |
SECTORAL ASSET MANAGEMENT INC | 187,016 | $4,191,029 | 0.82% |
Nebula Research & Development LLC | 21,858 | $489,838 | 0.26% |
Phocas Financial Corp. | 64,701 | $1,450,000 | 0.21% |